|
🐜
|
Revised international prognostic scoring system for myelodysplastic syndromes.
34 auth.
P. Greenberg,
H. Tuechler,
J. Schanz,
G. Sanz,
G. Garcia-Manero,
F. Solé,
J. Bennett,
D. Bowen,
P. Fenaux,
F. Dreyfus,
H. Kantarjian,
A. Kuendgen,
A. Levis,
L. Malcovati,
M. Cazzola,
...
J. Čermák,
C. Fonatsch,
M. L. Le Beau,
M. Slovak,
O. Krieger,
M. Luebbert,
J. Maciejewski,
S. Magalhães,
Y. Miyazaki,
M. Pfeilstöcker,
M. Sekeres,
W. Sperr,
R. Stauder,
S. Tauro,
P. Valent,
T. Vallespí,
A. A. van de Loosdrecht,
U. Germing,
D. Haase
|
11 |
2012 |
11
🐜
|
|
🐜
|
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.
14 auth.
L. Malcovati,
U. Germing,
A. Kuendgen,
M. D. Della Porta,
C. Pascutto,
R. Invernizzi,
A. Giagounidis,
B. Hildebrandt,
P. Bernasconi,
S. Knipp,
...
C. Strupp,
M. Lazzarino,
C. Aul,
M. Cazzola
|
9 |
2007 |
9
🐜
|
|
🐜
|
Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia.
18 auth.
E. Such,
U. Germing,
L. Malcovati,
J. Cervera,
A. Kuendgen,
M. D. Della Porta,
B. Nomdedeu,
L. Arenillas,
E. Luño,
B. Xicoy,
...
M. Amigo,
D. Valcárcel,
K. Nachtkamp,
Ilaria Ambaglio,
B. Hildebrandt,
I. Lorenzo,
M. Cazzola,
G. Sanz
|
8 |
2013 |
8
🐜
|
|
🐜
|
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.
23 auth.
C. Elena,
A. Gallì,
E. Such,
M. Meggendorfer,
U. Germing,
E. Rizzo,
J. Cervera,
E. Molteni,
A. Fasan,
E. Schuler,
...
Ilaria Ambaglio,
M. López-Pavía,
S. Zibellini,
A. Kuendgen,
E. Travaglino,
R. Sancho-Tello,
S. Catricalà,
A. Vicente,
T. Haferlach,
C. Haferlach,
G. Sanz,
L. Malcovati,
M. Cazzola
|
8 |
2016 |
8
🐜
|
|
🐜
|
Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)
12 auth.
L. Malcovati,
M. D. Della Porta,
C. Strupp,
Ilaria Ambaglio,
A. Kuendgen,
K. Nachtkamp,
...
E. Travaglino,
R. Invernizzi,
C. Pascutto,
M. Lazzarino,
U. Germing,
M. Cazzola
|
8 |
2011 |
8
🐜
|
|
🦁
|
Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid.
8 auth.
A. Kuendgen,
C. Strupp,
M. Aivado,
A. Bernhardt,
B. Hildebrandt,
R. Haas,
...
U. Germing,
N. Gattermann
|
8 |
2004 |
8
🦁
|
|
🐜
|
Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome
12 auth.
M. D. Della Porta,
L. Malcovati,
C. Strupp,
Ilaria Ambaglio,
A. Kuendgen,
Esther Zipperer,
...
E. Travaglino,
R. Invernizzi,
C. Pascutto,
M. Lazzarino,
U. Germing,
M. Cazzola
|
7 |
2011 |
7
🐜
|
|
🦁
|
The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all‐trans retinoic acid in patients with acute myeloid leukemia
10 auth.
A. Kuendgen,
M. Schmid,
R. Schlenk,
S. Knipp,
B. Hildebrandt,
C. Steidl,
...
U. Germing,
R. Haas,
H. Dōhner,
N. Gattermann
|
7 |
2006 |
7
🦁
|
|
🐜
|
A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy
19 auth.
M. Lübbert,
B. Rüter,
R. Claus,
C. Schmoor,
M. Schmid,
U. Germing,
A. Kuendgen,
V. Rethwisch,
A. Ganser,
U. Platzbecker,
...
O. Galm,
W. Brugger,
G. Heil,
B. Hackanson,
B. Deschler,
K. Döhner,
A. Hagemeijer,
P. Wijermans,
H. Döhner
|
7 |
2012 |
7
🐜
|
|
🐜
|
Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG).
30 auth.
V. Gaidzik,
R. Schlenk,
P. Paschka,
A. Stölzle,
D. Späth,
A. Kuendgen,
M. von Lilienfeld-Toal,
W. Brugger,
H. Derigs,
S. Kremers,
R. Greil,
A. Raghavachar,
M. Ringhoffer,
H. Salih,
M. Wattad,
...
H. Kirchen,
V. Runde,
G. Heil,
A. Petzer,
M. Girschikofsky,
M. Heuser,
S. Kayser,
G. Goehring,
Maria-Veronica Teleanu,
B. Schlegelberger,
A. Ganser,
J. Krauter,
L. Bullinger,
H. Döhner,
K. Döhner
|
7 |
2013 |
7
🐜
|
|
🐜
|
Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1–risk myelodysplastic syndrome and thrombocytopenia
13 auth.
A. Giagounidis,
G. Mufti,
P. Fenaux,
M. Sekeres,
J. Szer,
U. Platzbecker,
A. Kuendgen,
G. Gaidano,
W. Wiktor-Jedrzejczak,
Kuolung Hu,
...
P. Woodard,
A. Yang,
H. Kantarjian
|
7 |
2014 |
7
🐜
|
|
🐜
|
Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.
10 auth.
U. Germing,
C. Strupp,
A. Kuendgen,
S. Isa,
S. Knipp,
B. Hildebrandt,
...
A. Giagounidis,
C. Aul,
N. Gattermann,
R. Haas
|
7 |
2006 |
7
🐜
|
